|
Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine
|
02 January 2010 |
|
FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations
|
21 December 2009 |
|
Takeda and Pfizer to Co-Promote Takeda's Actos® for the Treatment of Type 2 Diabetes in China
|
16 December 2009 |
|
Pfizer Extends Commitment to Help Unemployed Americans
|
11 December 2009 |
|
Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System
|
10 December 2009 |
|
Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
|
02 December 2009 |
|
FDA Advisory Committee Finds Data Support SPIRIVA® HandiHaler®
|
20 November 2009 |
|
Pfizer and Medivation Initiate Two Phase 3 Trials of Dimebon
|
04 November 2009 |
|
Pfizer Reports Third-Quarter 2009 Results
|
22 October 2009 |
|
Pfizer And Wyeth Become One: Working Together For A Healthier Worldâ¢
|
16 October 2009 |
|
Pfizer Completes Acquisition Of Wyeth
|
16 October 2009 |
|
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau
|
15 October 2009 |
|
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry
|
09 October 2009 |
|
Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim
|
22 September 2009 |
|
Pfizer Concludes Previously Disclosed Settlement Agreement with U.S. Department of Justice
|
02 September 2009 |
|
New Analysis of the Pfizer-Sponsored TNT Clinical Trial
|
02 September 2009 |
|
Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research
|
20 August 2009 |
|
President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines
|
07 August 2009 |
|
Pfizer in Partnership with Shanghai Institutes for Biological Sciences for Drug Discovery Activities
|
30 July 2009 |
|
Pfizer Reports Second-Quarter 2009 Revenues of $11.0 Billion
|
23 July 2009 |